相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Efficacy of entecavir in treatment-naive patients with hepatitis B virus-related decompensated cirrhosis
Ju Hyun Shim et al.
JOURNAL OF HEPATOLOGY (2010)
Course of disease and survival after onset of decompensation in hepatitis B virus-related cirrhosis
Kausik Das et al.
LIVER INTERNATIONAL (2010)
Renal Dysfunction in Chronic Hepatitis B Patients Treated with Adefovir Dipivoxil
Nghi B. Ha et al.
HEPATOLOGY (2009)
EASL Clinical Practice Guidelines: Management of chronic hepatitis B
Patrick Marcellin et al.
JOURNAL OF HEPATOLOGY (2009)
Serum cystatin C level is a good prognostic marker in patients with cirrhotic ascites and normal serum creatinine levels
Yeon Seok Seo et al.
LIVER INTERNATIONAL (2009)
Natural course following the onset of cirrhosis in patients with chronic hepatitis B: a long-term follow-up study
Yi-Cheng Chen et al.
HEPATOLOGY INTERNATIONAL (2007)
Adefovir dipivoxil for wait-listed and post-liver transplantation patients with lamivudine-resistant hepatitis B: Final long-term results
Eugene Schiff et al.
LIVER TRANSPLANTATION (2007)
Hepatitis B virus-related cirrhosis: Natural history and treatment
CM Chu et al.
SEMINARS IN LIVER DISEASE (2006)
A comparison of entecavir and lamivudine for HBeAg-positive chronic hepatitis B
TT Chang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Entecavir versus lamivudine for patients with HBeAg-negative chronic hepatitis B
CL Lai et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Increased risk of adefovir resistance in patients with lamivudine-resistant chronic hepatitis B after 48 weeks of adefovir dipivoxil monotherapy
Yoon-Seon Lee et al.
HEPATOLOGY (2006)
Timing of lamivudine administration according to Child class in patients with decompensated cirrhosis
SH Bae et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2005)
Determinants of early mortality and benefits of lamivudine therapy in patients with hepatitis B virus-related decompensated liver cirrhosis
PL Tseng et al.
JOURNAL OF VIRAL HEPATITIS (2005)
Clinical course of lamivudine monotherapy in patients with decompensated cirrhosis due to HBeAg negative chronic HBV infection
S Manolakopoulos et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2004)
Lamivudine for patients with chronic hepatitis B and advanced liver disease
YF Liaw et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Model for End-Stage Liver Disease (MELD) and allocation of donor livers
R Wiesner et al.
GASTROENTEROLOGY (2003)
Determinants of early mortality in patients with decompensated chronic hepatitis B treated with antiviral therapy
RJ Fontana et al.
GASTROENTEROLOGY (2002)
Effect of lamivudine treatment on survival of 309 North American patients awaiting liver transplantation for chronic hepatitis B
RJ Fontana et al.
LIVER TRANSPLANTATION (2002)
MELD score is better than Child-Pugh score in predicting 3-month survival of patients undergoing transjugular intrahepatic portosystemic shunt
F Salerno et al.
JOURNAL OF HEPATOLOGY (2002)
Lamivudine treatment is beneficial in patients with severely decompensated cirrhosis and actively replicating hepatitis B infection awaiting liver transplantation: A comparative study using a matched, untreated cohort
FY Yao et al.
HEPATOLOGY (2001)
A multicenter United States-Canadian trial to assess lamivudine monotherapy before and after liver transplantation for chronic hepatitis
RP Perrillo et al.
HEPATOLOGY (2001)
Lamivudine treatment in patients with severely decompensated cirrhosis due to replicating hepatitis B infection
FY Yao et al.
JOURNAL OF HEPATOLOGY (2000)
Beneficial effects lamivudine in hepatitis B virus-related decompensated cirrhosis
D Kapoor et al.
JOURNAL OF HEPATOLOGY (2000)
Lamivudine treatment for decompensated cirrhosis resulting from chronic hepatitis B
JP Villeneuve et al.
HEPATOLOGY (2000)
分享论文
